Treosulfan-based conditioning in 6 pediatric and adolescent patients with non-malignant diseases and haematological malignancies

被引：0
|
作者：
Sovinz, P. [1 ]
Schwinger, W. [1 ]
Lackner, H. [1 ]
Benesch, M. [1 ]
Strenger, V. [1 ]
Seidel, M. [1 ]
Urban, C. [1 ]
机构：
[1] Med Univ Graz, Graz, Austria
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [41] Treosulfan/fludarabine/thiotepa conditioning for patients with advanced malignant haematologic lymphoproliferative diseases
    Baronciani, D.
    Depau, C.
    Pilo, F.
    Targhetta, C.
    Angelucci, E.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S249 - S250
  • [42] Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party
    J Wachowiak
    K-W Sykora
    J Cornish
    A Chybicka
    J R Kowalczyk
    E Gorczyńska
    M Choma
    G Grund
    C Peters
    Bone Marrow Transplantation, 2011, 46 : 1510 - 1518
  • [43] A randomised clinical phase 2 trial to compare treosulfan with busulfan based conditioning prior to allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases
    Sykora, K. -W.
    Beier, R.
    Bader, P.
    Styczynski, J.
    Schulz, A.
    Johann, G.
    Reinhardt, D.
    Schulte, J.
    Fagioli, F.
    Gruhn, B.
    Locatelli, F.
    Piras, S.
    Hoenig, M.
    Sedlacek, P.
    Bonanomi, S.
    Zecca, M.
    Caniglia, M.
    Cesaro, S.
    Mielcarek, M.
    Kalwak, K.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 91 - 92
  • [44] Pediatric Palliative Care for Children with Progressive Non-Malignant Diseases
    Siden, Harold
    CHILDREN-BASEL, 2018, 5 (02):
  • [45] CARCINOEMBRYONIC ANTIGEN (CEA) IN PATIENTS WITH MALIGNANT AND NON-MALIGNANT DISEASES
    ALSABTI, EAK
    KAMEL, A
    NEOPLASMA, 1979, 26 (05) : 603 - 609
  • [46] Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major
    Bernardo, Maria Ester
    Zecca, Marco
    Piras, Eugenia
    Vacca, Adriana
    Giorgiani, Giovanna
    Cugno, Chiara
    Caocci, Giovanni
    Comoli, Patrizia
    Mastronuzzi, Angela
    Merli, Pietro
    La Nasa, Giorgio
    Locatelli, Franco
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (04) : 548 - 551
  • [47] Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party
    Wachowiak, J.
    Sykora, K-W
    Cornish, J.
    Chybicka, A.
    Kowalczyk, J. R.
    Gorczynska, E.
    Choma, M.
    Grund, G.
    Peters, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 (12) : 1510 - 1518
  • [48] Fludarabine-based reduced-intensity conditioning for allogeneic transplantation in children with malignant and non-malignant diseases
    Gonzalez, M.
    Perez, A.
    Ramirez, M.
    Sevilla, J.
    Madero, L.
    Diaz, M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 61 - 61
  • [49] Fludarabine-based reduced-intensity conditioning for allogeneic transplantation in children with malignant and non-malignant diseases
    Díaz, M
    Pérez, A
    Vicent, MG
    Ramirez, M
    Castro, JG
    Madero, L
    BONE MARROW TRANSPLANTATION, 2006, 37 : S323 - S324
  • [50] Full-dose busulfan-based conditioning regimen for pediatric non-malignant disease
    Yabe, Hiromasa
    Imai, Eri
    Sugimoto, Akiko
    Otsubo, Keisuke
    Morimoto, Tsuyoshi
    Mochiduki, Hiroyuki
    Koike, Takashi
    Kato, Shunichi
    Yabe, Miharu
    BONE MARROW TRANSPLANTATION, 2018, 53 : 480 - 481
12345